Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes

Clinical and Experimental Immunology

Volumn 167, Issue 1, 2012, Pages 15-25

  Bemark, M ^a,b   Holmqvist, J ^a,b   Abrahamsson, J ^a   Mellgren, K ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

B cell; Haematopoietic stem cell transplantation; Lymphocyte development

Indexed keywords

B LYMPHOCYTE; CELL LINEAGE; CELL MATURATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; MEMBRANE RECONSTITUTION; MEMORY CELL; PHENOTYPE; PLASMA CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; WHOLE BODY RADIATION;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTE SUBSETS; CELL LINEAGE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INFECTION; LYMPHOPENIA; LYMPHOPOIESIS; MICE; TRANSPLANTATION CONDITIONING;

EID: 82655184677     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04469.x     Document Type: Review

References (106)

1. Ek T, Mellander L, Andersson B, Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatr Blood Cancer 2005; 44:461-8.
2. Torelli GF, Lucarelli B, Iori AP etal. The immune reconstitution after an allogeneic stem cell transplant correlates with the risk of graft-versus-host disease and cytomegalovirus infection. Leuk Res 2011; 35:1124-6.
3. Storek J, Geddes M, Khan F etal. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol 2008; 30:425-37.
4. Williams KM, Gress RE. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 2008; 21:579-96.
5. Sahdev I, O'Reilly R, Black P, Heller G, Hoffmann M. Interleukin-1 production following T-cell-depleted and unmodified marrow grafts. Pediatr Hematol Oncol 1996; 13:55-67.
6. Zimmerli W, Zarth A, Gratwohl A, Speck B. Neutrophil function and pyogenic infections in bone marrow transplant recipients. Blood 1991; 77:393-9.
7. Chklovskaia E, Nowbakht P, Nissen C, Gratwohl A, Bargetzi M, Wodnar-Filipowicz A. Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand. Blood 2004; 103:3860-8.
8. Collin MP, Hart DNJ, Jackson GH etal. The fate of human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med 2006; 203:27-33.
9. Gratama JW, Naipal A, Oljans P etal. T lymphocyte repopulation and differentiation after bone marrow transplantation. Early shifts in the ratio between T4+ and T8+ T lymphocytes correlate with the occurrence of acute graft-versus-host disease. Blood 1984; 63:1416-23.
10. Dumont-Girard F, Roux E, van Lier RA etal. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 1998; 92:4464-71.
11. van Leeuwen JE, van Tol MJ, Joosten AM, Wijnen JT, Khan PM, Vossen JM. Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse. Blood 1993; 82:1921-8.
12. Chalandon Y, Degermann S, Villard J etal. Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. Blood 2006; 107:389-96.
13. Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood 1996; 87:2594-603.
14. Reusser P, Riddell SR, Meyers JD, Greenberg PD. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78:1373-80.
15. Rufer N, Helg C, Chapuis B, Roosnek E. Human memory T cells: lessons from stem cell transplantation. Trends Immunol 2001; 22:136-41.
16. Cavazzana-Calvo M, André-Schmutz I, Dal Cortivo L, Neven B, Hacein-Bey-Abina S, Fischer A. Immune reconstitution after haematopoietic stem cell transplantation: obstacles and anticipated progress. Curr Opin Immunol 2009; 21:544-8.
17. Baumgartner C, Morell A, Hirt A etal. Humoral immune function in pediatric patients treated with autologous bone marrow transplantation for B cell non-Hodgkin's lymphoma. The influence of ex vivo marrow decontamination with anti-Y 29/55 monoclonal antibody and complement. Blood 1988; 71:1211-17.
18. Gokmen E, Raaphorst FM, Boldt DH, Teale JM. Ig heavy chain third complementarity determining regions (H CDR3s) after stem cell transplantation do not resemble the developing human fetal H CDR3s in size distribution and Ig gene utilization. Blood 1998; 92:2802-14.
19. Omazic B, Lundkvist I, Mattsson J, Permert J, Nasman-Bjork I. Memory B lymphocytes determine repertoire oligoclonality early after haematopoietic stem cell transplantation. Clin Exp Immunol 2003; 134:159-66.
20. Avanzini MA, Locatelli F, Dos Santos C etal. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells. Exp Hematol 2005; 33:480-6.
21. Storek J, Witherspoon RP, Storb R. Reconstitution of membrane IgD- (mIgD-) B cells after marrow transplantation lags behind the reconstitution of mIgD+ B cells. Blood 1997; 89:350-1.
22. Suzuki I, Milner EC, Glas AM etal. Immunoglobulin heavy chain variable region gene usage in bone marrow transplant recipients: lack of somatic mutation indicates a maturational arrest. Blood 1996; 87:1873-80.
23. Lausen BF, Hougs L, Schejbel L, Heilmann C, Barington T. Human memory B cells transferred by allogenic bone marrow transplantation contribute significantly to the antibody repertoire of the recipient. J Immunol 2004; 172:3305-18.
24. Wimperis JZ, Gottlieb D, Duncombe AS, Heslop HE, Prentice HG, Brenner MK. Requirements for the adoptive transfer of antibody responses to a priming antigen in man. J Immunol 1990; 144:541-7.
25. Auffermann-Gretzinger S, Lossos IS, Vayntrub TA etal. Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood 2002; 99:1442-8.
26. Bengtsson M, Smedmyr B, Festin R, Oberg G, Simonsson B, Tötterman TH. B lymphocyte regeneration in marrow and blood after autologous bone marrow transplantation: increased numbers of B cells carrying activation and progression markers. Leuk Res 1989; 13:791-7.
27. Pedrazzini A, Freedman AS, Andersen J etal. Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function. Blood 1989; 74:2203-11.
28. Okudaira H, Ishizaka K. Reaginic antibody formation in the mouse. XI. Participation of long-lived antibody-forming cells in persistent antibody formation. Cell Immunol 1981; 58:188-201.
29. Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998; 8:363-72.
30. van Tol MJ, Gerritsen EJ, de Lange GG etal. The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation. Blood 1996; 87:818-26.
31. Auletta JJ, Cooke KR. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease. Curr Opin Pediatr 2009; 21:30-8.
32. Wingard JR, Majhail NS, Brazauskas R etal. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol 2011; 29:2230-9.
33. Popat U, Carrum G, Heslop HE. Haemopoietic stem cell transplantation for acute lymphoblastic leukaemia. Cancer Treat Rev 2003; 29:3-10.
34. Tomblyn M, Chiller T, Einsele H etal. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant 2009; 44:453-558.
35. Atkinson K, Storb R, Prentice RL etal. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979; 53:720-31.
36. Engelhard D, Cordonnier C, Shaw PJ etal. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol 2002; 117:444-50.
37. Winston DJ, Schiffman G, Wang DC etal. Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med 1979; 91:835-41.
38. Kruetzmann S, Rosado MM, Weber H etal. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003; 197:939-45.
39. Storek J, Joseph A, Espino G etal. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood 2001; 98:3505-12.
40. Cohen S, Freeman T. Metabolic heterogeneity of human gamma-globulin. Biochem J 1960; 76:475-87.
41. Ljungman P, Wiklund-Hammarsten M, Duraj V etal. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990; 162:496-500.
42. Wahren B, Gahrton G, Linde A etal. Transfer and persistence of viral antibody-producing cells in bone marrow transplantation. J Infect Dis 1984; 150:358-65.
43. Ahuja A, Anderson SM, Khalil A, Shlomchik MJ. Maintenance of the plasma cell pool is independent of memory B cells. Proc Natl Acad Sci USA 2008; 105:4802-7.
44. Auletta JJ, Cooke KR, Solchaga LA, Deans RJ, van't Hof W. Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions. Biol Blood Marrow Transplant 2010; 16:891-906.
45. Chu VT, Fröhlich A, Steinhauser G etal. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol 2011; 12:151-9.
46. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002; 298:2199-202.
47. Gray D. A role for antigen in the maintenance of immunological memory. Nat Rev Immunol 2002; 2:60-5.
48. Lycke N, Bemark M. Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins. Mucosal Immunol 2010; 3:556-66.
49. Witherspoon RP, Kopecky K, Storb RF etal. Immunological recovery in 48 patients following syngeneic marrow transplantation or hematological malignancy. Transplantation 1982; 33:143-9.
50. Giebink GS, Warkentin PI, Ramsay NK, Kersey JH. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis 1986; 154:590-6.
51. Lortan JE, Vellodi A, Jurges ES, Hugh-Jones K. Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation. Clin Exp Immunol 1992; 88:512-9.
52. Lutz E, Ward KN, Szydlo R, Goldman JM. Cytomegalovirus antibody avidity in allogeneic bone marrow recipients: evidence for primary or secondary humoral responses depending on donor immune status. J Med Virol 1996; 49:61-5.
53. Tomblyn M, Chiller T, Einsele H etal. Guidelines for preventing infectious complications amonghematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15:1143-238.
54. Hallstrand TS, Sprenger JD, Agosti JM, Longton GM, Witherspoon RP, Henderson WR Jr. Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors. Blood 2004; 104:3086-90.
55. Gerritsen EJ, van Tol MJ, Lankester AC etal. Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation. Blood 1993; 82:3493-502.
56. Aucouturier P, Barra A, Intrator L etal. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987; 70:779-85.
57. Lum LG, Seigneuret MC, Orcutt-Thordarson N, Noges JE, Storb R. The regulation of immunoglobulin synthesis after HLA-identical bone marrow transplantation: VI. differential rates of maturation of distinct functional groups within lymphoid subpopulations in patients after human marrow grafting. Blood 1985; 65:1422-33.
58. Korsmeyer SJ, Elfenbein GJ, Goldman CK, Marshall SL, Santos GW, Waldmann TA. B cell, helper T cell, and suppressor T cell abnormalities contribute to disordered immunoglobulin synthesis in patients following bone marrow transplantation. Transplantation 1982; 33:184-90.
59. Keightley RG, Cooper MD, Lawton AR. The T cell dependence of B cell differentiation induced by pokeweed mitogen. J Immunol 1976; 117:1538-44.
60. Kirchner H, Tosato G, Blaese RM, Broder S, Magrath IT. Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro. J Immunol 1979; 122:1310-3.
61. Dilly SA, Sloane JP. Cellular composition of the spleen after human allogeneic bone marrow transplantation. J Pathol 1988; 155:151-60.
62. Sale GE, Alavaikko M, Schaefers KM, Mahan CT. Abnormal CD4:CD8 ratios and delayed germinal center reconstitution in lymph nodes of human graft recipients with graft-versus-host disease (GVHD): an immunohistological study. Exp Hematol 1992; 20:1017-21.
63. Allman D, Pillai S. Peripheral B cell subsets. Curr Opin Immunol 2008; 20:149-57.
64. Jackson SM, Wilson PC, James JA, Capra JD. Human B cell subsets. Adv Immunol 2008; 98:151-224.
65. Carsetti R, Köhler G, Lamers MC. Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med 1995; 181:2129-40.
66. Cuss AK, Avery DT, Cannons JL etal. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol 2006; 176:1506-16.
67. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005; 105:4390-8.
68. Lee J, Kuchen S, Fischer R, Chang S, Lipsky PE. Identification and characterization of a human CD5+ pre-naive B cell population. J Immunol 2009; 182:4116-26.
69. Suryani S, Fulcher DA, Santner-Nanan B etal. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood 2010; 115:519-29.
70. Andrews S, Wilson P. The anergic B cell. Blood 2010; 115:4976.
71. Wirths S, Lanzavecchia A. ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells. Eur J Immunol 2005; 35:3433-41.
72. Palanichamy A, Barnard J, Zheng B etal. Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol 2009; 182:5982-93.
73. Klein U, Rajewsky K, Küppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998; 188:1679-89.
74. Goodnow CC, Vinuesa CG, Randall KL, Mackay F, Brink R. Control systems and decision making for antibody production. Nat Immunol 2010; 11:681-8.
75. Bemark M, Bergqvist P, Stensson A, Holmberg A, Mattsson J, Lycke NY. A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development. J Immunol 2011; 186:1399-410.
76. Seifert M, Küppers R. Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. J Exp Med 2009; 206:2659-69.
77. Tangye SG, Good KL. Human IgM+CD27+ B cells: memory B cells or 'memory' B cells? J Immunol 2007; 179:13-19.
78. Weill J-C, Weller S, Reynaud C-A. Human marginal zone B cells. Annu Rev Immunol 2009; 27:267-85.
79. Wu Y-C, Kipling D, Leong HS, Martin V, Ademokun AA, Dunn-Walters DK. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood 2010; 116:1070-8.
80. Fecteau JF, Côté G, Néron S. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 2006; 177:3728-36.
81. Koethe S, Zander L, Koster S etal. Pivotal advance: CD45RB glycosylation is specifically regulated during human peripheral B cell differentiation. J Leukoc Biol 2011; 90:5-19.
82. Wrammert J, Smith K, Miller J etal. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008; 453:667-71.
83. Ghosn EEB, Sadate-Ngatchou P, Yang Y, Herzenberg LA, Herzenberg LA. Distinct progenitors for B-1 and B-2 cells are present in adult mouse spleen. Proc Natl Acad Sci USA 2011; 108:2879-84.
84. Weller S, Braun MC, Tan BK etal. Human blood IgM 'memory' B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004; 104:3647-54.
85. Weller S, Mamani-Matsuda M, Picard C etal. Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+ IgD+ CD27+ B cell repertoire in infants. J Exp Med 2008; 205:1331-42.
86. Kubicka U, Olszewski WL, Tarnowski W, Bielecki K, Ziolkowska A, Wierzbicki Z. Normal human immune peritoneal cells: subpopulations and functional characteristics. Scand J Immunol 1996; 44:157-63.
87. Donze HH, Lue C, Julian BA, Kutteh WH, Kantele A, Mestecky J. Human peritoneal B-1 cells and the influence of continuous ambulatory peritoneal dialysis on peritoneal and peripheral blood mononuclear cell (PBMC) composition and immunoglobulin levels. Clin Exp Immunol 1997; 109:356-61.
88. Boursier L, Farstad IN, Mellembakken JR, Brandtzaeg P, Spencer J. IgVH gene analysis suggests that peritoneal B cells do not contribute to the gut immune system in man. Eur J Immunol 2002; 32:2427-36.
89. Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70- J Exp Med 2011; 208:67-80.
90. Horgan KJ, Tanaka Y, Luce GE, van Seventer GA, Nutman TB, Shaw S. CD45RB expression defines two interconvertible subsets of human CD4+ T cells with memory function. Eur J Immunol 1994; 24:1240-3.
91. Corre E, Carmagnat M, Busson M etal. Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections. Haematologica 2010; 95:1025-9.
92. D'Orsogna LJ, Wright MP, Krueger RG etal. Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells. Biol Blood Marrow Transplant 2009; 15:795-803.
93. Greinix HT, Pohlreich D, Kouba M etal. Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease. Biol Blood Marrow Transplant 2008; 14:208-19.
94. Sarantopoulos S, Stevenson KE, Kim HT etal. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood 2009; 113:3865-74.
95. Marie-Cardine A, Divay F, Dutot I etal. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol 2008; 127:14-25.
96. Antin JH, Ault KA, Rappeport JM, Smith BR. B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytes. J Clin Invest 1987; 80:325-32.
97. Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990; 76:1647-56.
98. Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993; 12:387-98.
99. Velardi A, Cucciaioni S, Terenzi A etal. Acquisition of Ig isotype diversity after bone marrow transplantation in adults. A recapitulation of normal B cell ontogeny. J Immunol 1988; 141:815-20.
100. Elfenbein GJ, Bellis MM, Ravlin HM, Santos GW. Phenotypically immature B mu cells in the peripheral blood after bone marrow grafting in man. Exp Hematol 1982; 10:551-9.
101. Ault KA, Antin JH, Ginsburg D etal. Phenotype of recovering lymphoid cell populations after marrow transplantation. J Exp Med 1985; 161:1483-502.
102. Parra C, Roldán E, Brieva JA. Deficient expression of adhesion molecules by human CD5- B lymphocytes both after bone marrow transplantation and during normal ontogeny. Blood 1996; 88:1733-40.
103. Kagan JM, Champlin RE, Saxon A. B-cell dysfunction following human bone marrow transplantation: functional-phenotypic dissociation in the early posttransplant period. Blood 1989; 74:777-85.
104. Eyrich M, Leiler C, Lang P etal. A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors. Bone Marrow Transplant 2003; 32:379-90.
105. Uckun FM, Haissig S, Ledbetter JA etal. Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein. Blood 1992; 79:3369-79.
106. Koehne G, Zeller W, Stockschlaeder M, Zander AR. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19:149-56.